MRNA 39.39 (-0.43%)
US60770K1079BiotechnologyBiotechnology

Moderna (MRNA) Financial Metrics

This table shows a selected set of financial data points of Moderna (MRNA). You can choose which elements to display by selecting the desired chart and column.

MarketCap

Total Revenue

Free CashFlow

Year EPS Dividend Yield PE Ratio MarketCap Return On Assets Total Revenue Free CashFlow EBITDA Net Income Cash
2023 -12.34 0 -8.06 37.99B -0.21 6.75B -3.83B -3.21B -4.71B 2.91B
2022 21.22 0 8.46 70.77B 0.33 18.88B 4.58B 9.97B 8.36B 3.21B
2021 30.28 0 8.39 102.35B 0.76 17.74B 13.34B 13.53B 12.2B 6.85B
2020 -1.96 0 -53.33 39.84B -0.17 274M 1.96B -732M -747M 2.62B
2019 -1.55 0 -12.6 6.47B -0.29 48.04M -490.52M -545.72M -514.02M 235.88M
2018 -1.17 0 -13.05 5.02B -0.25 135.07M -436.63M -359.55M -384.73M 658.36M
2017 -0.95 0 0 0 -0.2 205.83M -389.89M -235.46M -255.92M 134.86M
2016 -0.73 0 0 0 -0.31 108.4M 33.59M -200.05M -216.21M 50.08M
2015 -0.02 0 0 0 -0.23 0 0 0 -1.11M 261.85K
2014 0 0 0 0 0 500K 0 0 -6.48M 1.82M

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.